394 related articles for article (PubMed ID: 21879445)
1. Deacetylation of nonhistone proteins by HDACs and the implications in cancer.
Peng L; Seto E
Handb Exp Pharmacol; 2011; 206():39-56. PubMed ID: 21879445
[TBL] [Abstract][Full Text] [Related]
2. Reversible acetylation of non histone proteins: role in cellular function and disease.
Batta K; Das C; Gadad S; Shandilya J; Kundu TK
Subcell Biochem; 2007; 41():193-212. PubMed ID: 17484129
[TBL] [Abstract][Full Text] [Related]
3. [Assay for inhibitory activity of histone deacetylase].
Yoshida M
Gan To Kagaku Ryoho; 2004 Apr; 31(4):507-11. PubMed ID: 15114691
[TBL] [Abstract][Full Text] [Related]
4. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Li Y; Seto E
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
[TBL] [Abstract][Full Text] [Related]
5. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
Yang XJ; Seto E
Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation by the acetylation of nonhistone proteins in humans -- a new target for therapeutics.
Das C; Kundu TK
IUBMB Life; 2005 Mar; 57(3):137-49. PubMed ID: 16036576
[TBL] [Abstract][Full Text] [Related]
7. Nonhistone protein acetylation as cancer therapy targets.
Singh BN; Zhang G; Hwa YL; Li J; Dowdy SC; Jiang SW
Expert Rev Anticancer Ther; 2010 Jun; 10(6):935-54. PubMed ID: 20553216
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy.
Botrugno OA; Robert T; Vanoli F; Foiani M; Minucci S
Clin Cancer Res; 2012 May; 18(9):2436-42. PubMed ID: 22512979
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors.
Marks PA; Richon VM; Miller T; Kelly WK
Adv Cancer Res; 2004; 91():137-68. PubMed ID: 15327890
[TBL] [Abstract][Full Text] [Related]
10. Histone acetylation in gene regulation.
Verdone L; Agricola E; Caserta M; Di Mauro E
Brief Funct Genomic Proteomic; 2006 Sep; 5(3):209-21. PubMed ID: 16877467
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of proteins as novel target for antitumor therapy: review article.
Di Gennaro E; Bruzzese F; Caraglia M; Abruzzese A; Budillon A
Amino Acids; 2004 Jul; 26(4):435-41. PubMed ID: 15290351
[TBL] [Abstract][Full Text] [Related]
12. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
[TBL] [Abstract][Full Text] [Related]
13. Acetylation of non-histone proteins modulates cellular signalling at multiple levels.
Spange S; Wagner T; Heinzel T; Krämer OH
Int J Biochem Cell Biol; 2009 Jan; 41(1):185-98. PubMed ID: 18804549
[TBL] [Abstract][Full Text] [Related]
14. Regulation of protein turnover by acetyltransferases and deacetylases.
Sadoul K; Boyault C; Pabion M; Khochbin S
Biochimie; 2008 Feb; 90(2):306-12. PubMed ID: 17681659
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors and cancer: from cell biology to the clinic.
Hess-Stumpp H
Eur J Cell Biol; 2005 Mar; 84(2-3):109-21. PubMed ID: 15819394
[TBL] [Abstract][Full Text] [Related]
16. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
Hutt DM; Roth DM; Marchal C; Bouchecareilh M
Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
[TBL] [Abstract][Full Text] [Related]
17. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
Yoshida M; Shimazu T; Matsuyama A
Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
[TBL] [Abstract][Full Text] [Related]
18. Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics.
Selvi RB; Kundu TK
Biotechnol J; 2009 Mar; 4(3):375-90. PubMed ID: 19296442
[TBL] [Abstract][Full Text] [Related]
19. Roles of histone acetyltransferases and deacetylases in gene regulation.
Kuo MH; Allis CD
Bioessays; 1998 Aug; 20(8):615-26. PubMed ID: 9780836
[TBL] [Abstract][Full Text] [Related]
20. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.
Bush EW; McKinsey TA
Circ Res; 2010 Feb; 106(2):272-84. PubMed ID: 20133912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
